Quick Overview: Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association® (ADA), and Dr. Kamlesh Khunti, ... Welcome to today's session! Stay updated with the latest advancements in medicine through our daily expert-led webinars and ... During this webinar, Dr. Robert Gabbay, Dr. Steven Brunton, and Dr. Kamlesh Khunti, discuss the latest research on the impact of ...

Therapeutic Inertia What You Need - Detailed Overview & Context

Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association® (ADA), and Dr. Kamlesh Khunti, ... Welcome to today's session! Stay updated with the latest advancements in medicine through our daily expert-led webinars and ... During this webinar, Dr. Robert Gabbay, Dr. Steven Brunton, and Dr. Kamlesh Khunti, discuss the latest research on the impact of ... Swapnil Hiremath, MD, MPH, FASN and Niteesh K. Choudhry, MD, PhD discuss the critical aspects of non-adherence and ... This webinar is designed for health care administrators, health care executives, payors, and change leaders in the health care ... In your busy practice are your patients not getting to their A1C goals and

Project ECHO Diabetes in the Time of COVID-19 Series presented by Jay H. Shubrook, DO, FAAFP, FACOFP; Professor, Touro ... ... Pharmacists and federally qualified Health Centers as they help to overcome Learn practical strategies for overcoming Project ECHO Diabetes in the Time of COVID-19 Series presented by Robert Gabbay, MD, PhD A Continuing Medical Education ...

Photo Gallery

Therapeutic Inertia: What You Need to Know
Therapeutic Inertia in Multiple Sclerosis: A Call To Action
Girish Mathur - Overcoming Therapeutic Inertia in Diabetes
Overcoming Therapeutic Inertia - Overview
Addressing Therapeutic Inertia
Therapeutic Inertia Making MS Worse? What's your docs Treatment Style?
Strategies to Overcome Therapeutic Inertia
Multiple Sclerosis Vlog: Therapeutic Inertia is Worsening Your MS
Therapeutic Inertia and Medication Non-Adherence in Hypertension Treatment
Overcoming Therapeutic Inertia in Type 2 Diabetes—Benefiting Patients, Clinicians and Health Systems
Overcoming Therapeutic Inertia: Initiating, Intensifying, and De-intensifying Insulin Clip 1
Insulin Dosing & Therapeutic Inertia in the Time of COVID-19
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored